FMP
PMV Pharmaceuticals, Inc.
PMVP
NASDAQ
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
0.883 USD
-0.0011 (-0.125%)
About
ceo
Dr. David H. Mack Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.pmvpharma.comexchange
NASDAQ
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
CIK
0001699382
ISIN
US69353Y1038
CUSIP
69353Y103
Address
8 Clarke Drive
Phone
609 642 6670
Country
US
Employee
47
IPO Date
Sep 25, 2020
Key Executives
Name
Title
Pay
Year Born
Dr. Arnold J. Levine Ph.D.
Co-Founder, Independent Director & Membe...
140k
1940
Ms. Crystal Zuckerman
Vice President of Human Resources
0
N/A
Mr. Tim Smith
Senior Vice President and Head of Corpor...
0
N/A
Dr. Deepika Jalota Pharm.D.
Chief Development Officer
638.36k
1977
Mr. Michael Carulli
Chief Financial Officer
532.8k
1974
Ms. Laura De Leon
Vice President & Head of Clinical Operat...
0
N/A
Mr. Robert Ticktin J.D.
General Counsel, Chief Operating Officer...
0
1962
Dr. Marc Fellous M.D.
Senior Vice President and Head of Clinic...
0
N/A
Dr. Binh Vu Ph.D.
Senior Vice President of Drug Discovery ...
0
N/A
Dr. David H. Mack Ph.D.
Co-Founder, Chief Executive Officer, Pre...
943.07k
1962
As of December 31, 2024, the total employee count stands at 47, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
